336 related articles for article (PubMed ID: 29016888)
1. Metabolic heterogeneity and plasticity of glioma stem cells in a mouse glioblastoma model.
Shibao S; Minami N; Koike N; Fukui N; Yoshida K; Saya H; Sampetrean O
Neuro Oncol; 2018 Feb; 20(3):343-354. PubMed ID: 29016888
[TBL] [Abstract][Full Text] [Related]
2. VDAC2 interacts with PFKP to regulate glucose metabolism and phenotypic reprogramming of glioma stem cells.
Zhou K; Yao YL; He ZC; Chen C; Zhang XN; Yang KD; Liu YQ; Liu Q; Fu WJ; Chen YP; Niu Q; Ma QH; Zhou R; Yao XH; Zhang X; Cui YH; Bian XW; Shi Y; Ping YF
Cell Death Dis; 2018 Sep; 9(10):988. PubMed ID: 30250190
[TBL] [Abstract][Full Text] [Related]
3. Integrated analysis identifies different metabolic signatures for tumor-initiating cells in a murine glioblastoma model.
Saga I; Shibao S; Okubo J; Osuka S; Kobayashi Y; Yamada S; Fujita S; Urakami K; Kusuhara M; Yoshida K; Saya H; Sampetrean O
Neuro Oncol; 2014 Aug; 16(8):1048-56. PubMed ID: 24860177
[TBL] [Abstract][Full Text] [Related]
4. The LIM-only transcription factor LMO2 determines tumorigenic and angiogenic traits in glioma stem cells.
Kim SH; Kim EJ; Hitomi M; Oh SY; Jin X; Jeon HM; Beck S; Jin X; Kim JK; Park CG; Chang SY; Yin J; Kim T; Jeon YJ; Song J; Lim YC; Lathia JD; Nakano I; Kim H
Cell Death Differ; 2015 Sep; 22(9):1517-25. PubMed ID: 25721045
[TBL] [Abstract][Full Text] [Related]
5. Targeting metabolic plasticity in glioma stem cells in vitro and in vivo through specific inhibition of c-Src by TAT-Cx43
Pelaz SG; Jaraíz-Rodríguez M; Álvarez-Vázquez A; Talaverón R; García-Vicente L; Flores-Hernández R; Gómez de Cedrón M; Tabernero M; Ramírez de Molina A; Lillo C; Medina JM; Tabernero A
EBioMedicine; 2020 Dec; 62():103134. PubMed ID: 33254027
[TBL] [Abstract][Full Text] [Related]
6. Metabolic state of glioma stem cells and nontumorigenic cells.
Vlashi E; Lagadec C; Vergnes L; Matsutani T; Masui K; Poulou M; Popescu R; Della Donna L; Evers P; Dekmezian C; Reue K; Christofk H; Mischel PS; Pajonk F
Proc Natl Acad Sci U S A; 2011 Sep; 108(38):16062-7. PubMed ID: 21900605
[TBL] [Abstract][Full Text] [Related]
7. Interplay between TRAP1 and Sirtuin-3 Modulates Mitochondrial Respiration and Oxidative Stress to Maintain Stemness of Glioma Stem Cells.
Park HK; Hong JH; Oh YT; Kim SS; Yin J; Lee AJ; Chae YC; Kim JH; Park SH; Park CK; Park MJ; Park JB; Kang BH
Cancer Res; 2019 Apr; 79(7):1369-1382. PubMed ID: 30683653
[TBL] [Abstract][Full Text] [Related]
8. A ketogenic diet attenuates proliferation and stemness of glioma stem‑like cells by altering metabolism resulting in increased ROS production.
Ji CC; Hu YY; Cheng G; Liang L; Gao B; Ren YP; Liu JT; Cao XL; Zheng MH; Li SZ; Wan F; Han H; Fei Z
Int J Oncol; 2020 Feb; 56(2):606-617. PubMed ID: 31894296
[TBL] [Abstract][Full Text] [Related]
9. Metabolic activation of mitochondria in glioma stem cells promotes cancer development through a reactive oxygen species-mediated mechanism.
Yuan S; Lu Y; Yang J; Chen G; Kim S; Feng L; Ogasawara M; Hammoudi N; Lu W; Zhang H; Liu J; Colman H; Lee JS; Li XN; Xu RH; Huang P; Wang F
Stem Cell Res Ther; 2015 Oct; 6():198. PubMed ID: 26472041
[TBL] [Abstract][Full Text] [Related]
10. Tetraspanin CD9 stabilizes gp130 by preventing its ubiquitin-dependent lysosomal degradation to promote STAT3 activation in glioma stem cells.
Shi Y; Zhou W; Cheng L; Chen C; Huang Z; Fang X; Wu Q; He Z; Xu S; Lathia JD; Ping Y; Rich JN; Bian XW; Bao S
Cell Death Differ; 2017 Jan; 24(1):167-180. PubMed ID: 27740621
[TBL] [Abstract][Full Text] [Related]
11. Short-Term Differentiation of Glioblastoma Stem Cells Induces Hypoxia Tolerance.
Skjellegrind HK; Fayzullin A; Johnsen EO; Eide L; Langmoen IA; Moe MC; Vik-Mo EO
Neurochem Res; 2016 Jul; 41(7):1545-58. PubMed ID: 26915110
[TBL] [Abstract][Full Text] [Related]
12. Repurposing phenformin for the targeting of glioma stem cells and the treatment of glioblastoma.
Jiang W; Finniss S; Cazacu S; Xiang C; Brodie Z; Mikkelsen T; Poisson L; Shackelford DB; Brodie C
Oncotarget; 2016 Aug; 7(35):56456-56470. PubMed ID: 27486821
[TBL] [Abstract][Full Text] [Related]
13. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth.
Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S
Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911
[TBL] [Abstract][Full Text] [Related]
14. Prediction of Glioma Stemlike Cell Infiltration in the Non-Contrast-Enhancing Area by Quantitative Measurement of Lactate on Magnetic Resonance Spectroscopy in Glioblastoma.
Inoue A; Nishikawa M; Ohnishi T; Yano H; Kanemura Y; Ohtsuka Y; Ozaki S; Nakamura Y; Matsumoto S; Suehiro S; Yamashita D; Shigekawa S; Watanabe H; Kitazawa R; Tanaka J; Kunieda T
World Neurosurg; 2021 Sep; 153():e76-e95. PubMed ID: 34144167
[TBL] [Abstract][Full Text] [Related]
15. Stem cell signature in glioblastoma: therapeutic development for a moving target.
Nakano I
J Neurosurg; 2015 Feb; 122(2):324-30. PubMed ID: 25397368
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential of targeting glucose metabolism in glioma stem cells.
Nakano I
Expert Opin Ther Targets; 2014 Nov; 18(11):1233-6. PubMed ID: 25077882
[TBL] [Abstract][Full Text] [Related]
17. The hypoxic peri-arteriolar glioma stem cell niche, an integrated concept of five types of niches in human glioblastoma.
Aderetti DA; Hira VVV; Molenaar RJ; van Noorden CJF
Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):346-354. PubMed ID: 29684521
[TBL] [Abstract][Full Text] [Related]
18. The contribution of ketone bodies to glycolytic inhibition for the treatment of adult and pediatric glioblastoma.
Vallejo FA; Shah SS; de Cordoba N; Walters WM; Prince J; Khatib Z; Komotar RJ; Vanni S; Graham RM
J Neurooncol; 2020 Apr; 147(2):317-326. PubMed ID: 32096068
[TBL] [Abstract][Full Text] [Related]
19. Characterization of glioma stem-like cells from human glioblastomas.
Yamamuro S; Okamoto Y; Sano E; Ochiai Y; Ogino A; Ohta T; Hara H; Ueda T; Nakayama T; Yoshino A; Katayama Y
Int J Oncol; 2015 Jul; 47(1):91-6. PubMed ID: 25955568
[TBL] [Abstract][Full Text] [Related]
20. TSPO deficiency induces mitochondrial dysfunction, leading to hypoxia, angiogenesis, and a growth-promoting metabolic shift toward glycolysis in glioblastoma.
Fu Y; Wang D; Wang H; Cai M; Li C; Zhang X; Chen H; Hu Y; Zhang X; Ying M; He W; Zhang J
Neuro Oncol; 2020 Feb; 22(2):240-252. PubMed ID: 31563962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
